An annual award worth €200,000, recognising researchers whose scientific discoveries have had a major impact on the care of patients with cancer.
Launched in 2025, the Gustave Roussy Prize is awarded each year to a prominent figure in oncology research whose scientific breakthroughs in the fields of cancer diagnosis, treatment, or prevention have significantly improved patient care or led to a better understanding of the disease.
Created to mark the 150th anniversary of Professor Gustave Roussy’s birth and the centenary of the Institute that bears his name, the prize is a tribute to the pioneer who revolutionised cancer care by establishing, in 1921, the first consultation dedicated to patients with tumours.
The prize highlights innovation and scientific commitment that led to tangible, lasting benefits for patients, in perfect alignment with Gustave Roussy’s mission: to cure more patients, more effectively and more sustainably. It is endowed with €200,000: €100,000 for the laureate's free use, and €100,000 to support an innovative research project in oncology.
The Gustave Roussy Prize is awarded annually by the Gustave Roussy Foundation, with the support of Pierre Fabre as the founding sponsor. It is open to researchers of all nationalities. An independent jury of international experts selects the laureate solely on scientific excellence and clinical impact, regardless of discipline or institution.
List of laureates
2025: Professor Charles Swanton
Call for applications
The call for applications for the 2026 edition of the Gustave Roussy Prize is now closed. The prize will be awarded to the laureate on 4 February 2026, to mark World Cancer Day.
The link to access the next call for applications will be published on this page during the opening period.
